Spots Global Cancer Trial Database for A Study of BBI608 in Adult Patients With Advanced Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of BBI608 in Adult Patients With Advanced Malignancies
Official Title: A Phase I Clinical Study of BBI608 in Adult Patients With Advanced Malignancies
Study ID: NCT01775423
Conditions
Interventions
Study Description
Brief Summary: This is an open label, single arm, dose escalation study of BBI608 in patients with advanced malignancies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Institute for Translational Oncology Research, Greenville Hospital System, Greenville, South Carolina, United States
Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada
Jewish General Hospital, Montreal, Quebec, Canada
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
